Back to Search Start Over

[68Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas.

Authors :
Guberina, Nika
Kessler, Lukas
Pöttgen, Christoph
Guberina, Maja
Metzenmacher, Martin
Herrmann, Ken
Mucha, Maja
Rischpler, Christoph
Indenkämpen, Frank
Siveke, Jens T.
Treckmann, Jürgen
Umutlu, Lale
Kasper, Stefan
Fendler, Wolfgang P.
Stuschke, Martin
Source :
Scientific Reports; 9/28/2022, Vol. 12 Issue 1, p1-14, 14p
Publication Year :
2022

Abstract

Biliary-tract-carcinomas (BTC), pancreatic-ductal-adenocarcinomas (PDAC) and adenoidcystic-carcinomas (AC) have in common that they are traditionally treated with large clinical-target-volumes (CTV). The aim of this study is to examine the impact of pretreatment-[<superscript>68</superscript>Ga]FAPI-PET/CT on target-volume-definition and posttreatment-[<superscript>68</superscript>Ga]FAPI-PET/CT-response-assessment for BTC-, PDAC- and AC-patients referred to radiation-therapy. All consecutive BTC-, PDAC-, and AC-patients who received pretreatment-[<superscript>68</superscript>Ga]FAPI-PET/CT±[<superscript>18</superscript>F]FDG-PET/CT were included from 01.01.2020 to 01.03.2022. MTV and SUV<subscript>max</subscript> were separately generated based on [<superscript>68</superscript>Ga]FAPI- and [<superscript>18</superscript>F]FDG-PET/CT-images. A [<superscript>68</superscript>Ga]FAPI- and [<superscript>18</superscript>F]FDG-based-CTV was defined. Treatment-plans were compared. Treatment-response was reassessed by a second [<superscript>68</superscript>Ga]FAPI-PET/CT and [<superscript>18</superscript>F]FDG-PET/CT after treatment-completion. Intermodality comparison of lesion-to-background-ratios [SUV<subscript>max_lesion</subscript>/SUV<subscript>mean_background</subscript>] for individual timepoints t<subscript>1</subscript> and t<subscript>2</subscript> revealed significant higher values for [<superscript>68</superscript>Ga]FAPI compared to [<superscript>18</superscript>F]FDG (t<subscript>1</subscript>, p = 0.008; t<subscript>2</subscript>, p = 0.005). Intermodality comparison of radiation-therapy-plans showed that [<superscript>68</superscript>Ga]FAPI-based planning resulted in D100% = 97.2% and V95% = 98.8% for the [<superscript>18</superscript>F]FDG-MTV. [<superscript>18</superscript>F]FDG-based-planning resulted in D100% = 35.9% and V95% = 78.1% for [<superscript>68</superscript>Ga]FAPI-MTV. [<superscript>18</superscript>F]FDG-based-planning resulted only in 2 patients in V95% > 95% for [<superscript>68</superscript>Ga]FAPI-MTV, and in 1 patient in D100% > 97% for [<superscript>68</superscript>Ga]FAPI-MTV. GTV-coverage in terms of V95% was 76.4% by [<superscript>18</superscript>F]FDG-based-planning and 99.5% by [<superscript>68</superscript>Ga]FAPI-based-planning. Pretreatment [<superscript>68</superscript>Ga]FAPI-PET/CT enhances radiation-treatment-planning in this particular group of patients. While perilesional and tumoral follow-up [<superscript>18</superscript>F]FDG-uptake behaved uniformly, perilesional and tumoral reaction may differ in follow-up [<superscript>68</superscript>Ga]FAPI-imaging. Complementary [<superscript>68</superscript>Ga]FAPI- and [<superscript>18</superscript>F]FDG-imaging enhance treatment-response-assessment. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20452322
Volume :
12
Issue :
1
Database :
Complementary Index
Journal :
Scientific Reports
Publication Type :
Academic Journal
Accession number :
159382060
Full Text :
https://doi.org/10.1038/s41598-022-20447-6